Extraction Form Preview:

Arm Name Suggestions

No arms specified.

Design Details and Enrollment

Question 1 Duration of the study and its median follow up time.

Baseline Characteristics Fields

Question 1 The age of the participants.

Question 2 Inclusion Criteria.

Question 3 Characteristics of the genetic mutations in AML patients.

Question 4 Number of previous lines of chemotherapy/ Percentages of relapse and refractory AML.

Outcome Name Suggestions

Outcome Title	Note
ORR
CR
CRi
PR
ORR/RI40
ORR/RI72
MLFR
>1% TEAE
Overall Survival.
Overall Survival in subjects who had response.

Outcome Details

Question 1 Time to response and duration of the response.

Adverse Events

Arm or Total	Title	Description
Total

Exit Disclaimer

This graphic notice, , means that you are leaving this Federal Government Web site and entering a non-Federal Web site.
This external link provides additional information that is consistent with the intended purpose of a Federal site.
Linking to a non-Federal site does not constitute an endorsement by the Department of Health and Human Services (HHS) or any of its employees of the sponsors or the information and products presented on the site.
HHS cannot attest to the accuracy of information provided by this link.
You will be subject to the destination site's privacy policy when you follow the link.